Class information for:
Level 1: PLASMINOGEN ACTIVATOR INHIBITOR 1//PAI 1//FIBRINOLYSIS

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
799 2970 38.9 81%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
560 13740 UROKINASE RECEPTOR//FIBRINOLYSIS//PAI 1

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 PLASMINOGEN ACTIVATOR INHIBITOR 1 Author keyword 94 27% 10% 293
2 PAI 1 Author keyword 74 26% 8% 252
3 FIBRINOLYSIS Journal 56 27% 6% 176
4 4G 5G POLYMORPHISM Author keyword 48 91% 1% 20
5 PLASMINOGEN ACTIVATOR INHIBITOR Author keyword 43 27% 5% 136
6 PLASMINOGEN ACTIVATOR INHIBITOR TYPE 1 Author keyword 37 37% 3% 80
7 PHARMACEUT BIOL PHYTOPHARMACOL Address 32 49% 2% 47
8 PAI 1 INHIBITOR Author keyword 21 90% 0% 9
9 TISSUE TYPE PLASMINOGEN ACTIVATOR Author keyword 18 16% 3% 100
10 CELLULAR PROT SCI Address 15 67% 0% 14

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 PLASMINOGEN ACTIVATOR INHIBITOR 1 94 27% 10% 293 Search PLASMINOGEN+ACTIVATOR+INHIBITOR+1 Search PLASMINOGEN+ACTIVATOR+INHIBITOR+1
2 PAI 1 74 26% 8% 252 Search PAI+1 Search PAI+1
3 FIBRINOLYSIS 56 12% 15% 441 Search FIBRINOLYSIS Search FIBRINOLYSIS
4 4G 5G POLYMORPHISM 48 91% 1% 20 Search 4G+5G+POLYMORPHISM Search 4G+5G+POLYMORPHISM
5 PLASMINOGEN ACTIVATOR INHIBITOR 43 27% 5% 136 Search PLASMINOGEN+ACTIVATOR+INHIBITOR Search PLASMINOGEN+ACTIVATOR+INHIBITOR
6 PLASMINOGEN ACTIVATOR INHIBITOR TYPE 1 37 37% 3% 80 Search PLASMINOGEN+ACTIVATOR+INHIBITOR+TYPE+1 Search PLASMINOGEN+ACTIVATOR+INHIBITOR+TYPE+1
7 PAI 1 INHIBITOR 21 90% 0% 9 Search PAI+1+INHIBITOR Search PAI+1+INHIBITOR
8 TISSUE TYPE PLASMINOGEN ACTIVATOR 18 16% 3% 100 Search TISSUE+TYPE+PLASMINOGEN+ACTIVATOR Search TISSUE+TYPE+PLASMINOGEN+ACTIVATOR
9 PAI 1 GENE 8 60% 0% 9 Search PAI+1+GENE Search PAI+1+GENE
10 PAI 1 DEFICIENCY 8 100% 0% 5 Search PAI+1+DEFICIENCY Search PAI+1+DEFICIENCY

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 RAPID INHIBITOR 152 75% 4% 110
2 PAI 1 125 37% 9% 266
3 FAST ACTING INHIBITOR 98 63% 3% 100
4 PLASMINOGEN ACTIVATOR INHIBITOR 1 66 13% 15% 460
5 T PA 59 27% 6% 189
6 PAI 1 GENE 59 51% 3% 84
7 4G 5G POLYMORPHISM 46 46% 2% 74
8 PLASMINOGEN ACTIVATOR INHIBITOR 37 14% 8% 239
9 IMPAIRED FIBRINOLYSIS 30 60% 1% 32
10 4G 4G GENOTYPE 27 78% 1% 18

Journals


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 FIBRINOLYSIS 56 27% 6% 176
2 FIBRINOLYSIS & PROTEOLYSIS 13 22% 2% 54

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Small molecules inhibitors of plasminogen activator inhibitor-1-An overview 2015 2 81 79%
Mechanisms of disease: Plasminogen-activator inhibitor type 1 and coronary artery disease. 2000 485 97 60%
PAI-1 and the metabolic syndrome - Links, causes, and consequences 2006 144 112 66%
The role of plasminogen activator inhibitor 1 in renal and cardiovascular diseases 2009 71 103 49%
Pleiotropic functions of plasminogen activator inhibitor-1 2005 171 134 63%
The association between plasminogen activator inhibitor type 1 (PAI-1) levels, PAI-1 4G/5G polymorphism, and myocardial infarction: a Mendelian randomization meta-analysis 2014 5 94 64%
Rasminogen activator inhibitor-1, adipose tissue and insulin resistance 2007 83 59 61%
The Biochemistry, Physiology and Pathological roles of PAI-1 and the requirements for PAI-1 inhibition in vivo 2012 22 159 83%
Obesity and impaired fibrinolysis: role of adipose production of plasminogen activator inhibitor-1 2004 137 70 71%
PAI-1, progress in understanding the clinical problem and its aetiology 2012 40 87 48%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 PHARMACEUT BIOL PHYTOPHARMACOL 32 49% 1.6% 47
2 CELLULAR PROT SCI 15 67% 0.5% 14
3 CLIN CHEM BLOOD COAGULAT 7 40% 0.5% 14
4 EPI 9936 5 63% 0.2% 5
5 DEMOG STAT STUDIES 4 67% 0.1% 4
6 PHARMACOL THROMBOSIS ATHEROSCLEROSIS 3 57% 0.1% 4
7 INTERNAL INTENS MED 3 60% 0.1% 3
8 INTERNAL MED THER EUTCLIN MED 2 67% 0.1% 2
9 CELLULAR PROTEIN SCI 2 50% 0.1% 3
10 MED WHITTINGTON HOSP MED 2 50% 0.1% 3

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000149681 PLASMINOGEN ACTIVATOR INHIBITION//PLASMIN INHIBITION//T PA ANTIGEN
2 0.0000127845 VITRONECTIN//KERCKHOFF KLIN HAEMOSTASIS UNIT//BIOL BUNKYO KU
3 0.0000127685 MEGSIN//SERPINB2//PAI 2
4 0.0000125440 CLIN PATHOL BIOCHEM//ALPHA2 ANTIPLASMIN//TC 99M NC100668
5 0.0000120731 PLATELET PMN INTERACTION//ATHLETIC HORSE//B TG
6 0.0000090212 SPECIALTY CARE SERV//PULM CRIT CARE MEDMED//ANTIPLASMINS
7 0.0000087665 STAPHYLOKINASE//FIBRINOLYSIS//PLASMINOGEN
8 0.0000083822 UROKINASE RECEPTOR//UPAR//UPA
9 0.0000081280 FIBRINOGEN//BLOOD VISCOSITY//PLASMA VISCOSITY
10 0.0000072278 KANEMATSU//ISOLATED GLOMERULI//NEPHROL A